Hanne Capital

Total investments

14

Average round size

27M

Portfolio companies

12

Rounds per year

2.33

Lead investments

6

Follow on index

0.14

Stages of investment
Venture
Areas of investment
BiotechnologyHealth CareMedical DeviceMedicalPharmaceuticalTherapeuticsBiopharma

Summary

Hanne Capital appeared to be the VC, which was created in 2017.

Besides them, we counted 1 critical employee of this fund in our database.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Hanne Capital, startups are often financed by Nest.Bio Ventures, Viventures, Sequoia Capital China. The meaningful sponsors for the fund in investment in the same round are VI Ventures, Sequoia Capital China, Legend Star.

Among the various public portfolio startups of the fund, we may underline HiFiBiO Among the most successful fund investment fields, there are Pharmaceutical, Health Care. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The usual things for fund are deals in the range of 50 - 100 millions dollars. The important activity for fund was in 2019. The fund is constantly included in 2-6 deals per year.

Show more

Investments analytics

Analytics

Total investments
14
Lead investments
6
Rounds per year
2.33
Follow on index
0.14
Investments by industry
  • Biotechnology (8)
  • Health Care (7)
  • Pharmaceutical (3)
  • Biopharma (2)
  • Medical Device (1)
  • Show 2 more
Investments by region
  • China (9)
  • France (1)
  • United States (1)
Peak activity year
2020

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
4
Group Appearance index
0.71

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
EOC Pharma Group 02 Dec 2019 Biotechnology, Health Care, Pharmaceutical, Biopharma Late Stage Venture 77M China, Shanghai
Ningkang Ruizhu 27 Sep 2019 Health Care Seed 10M Guangdong Province, Xiangzhou District, China

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.